BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33990838)

  • 1. Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.
    Hiraki T; Fukuoka K; Mori M; Arakawa Y; Matsushita Y; Hibiya Y; Honda S; Kobayashi M; Tanami Y; Ichimura K; Hirato J; Kurihara J; Nakazawa A; Koh K
    J Neuropathol Exp Neurol; 2021 Jun; 80(6):552-557. PubMed ID: 33990838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
    Ricklefs FL; Fritzsche F; Winkler B; Meissner B; Dührsen L; Westphal M; Rutkowski S; Martens T; Schüller U
    Childs Nerv Syst; 2019 Jun; 35(6):1029-1033. PubMed ID: 30796558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
    Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
    Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
    Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
    Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
    Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.
    O'Halloran K; Margol A; Davidson TB; Estrine D; Tamrazi B; Cotter JA; Ji J; Biegel JA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
    Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
    Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
    Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
    Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence of medulloblastoma 19 years after the initial diagnosis.
    Amagasaki K; Yamazaki H; Koizumi H; Hashizume K; Sasaguchi N
    Childs Nerv Syst; 1999 Sep; 15(9):482-5. PubMed ID: 10502011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of adult medulloblastomas: A review of the literature and perspectives].
    Riffaud L; Hénaux PL
    Neurochirurgie; 2016 Feb; 62(1):46-52. PubMed ID: 26657111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report.
    Yang SY; Wang KC; Cho BK; Kim YY; Lim SY; Park SH; Kim IH; Kim SK
    J Neurosurg; 2005 May; 102(4 Suppl):417-22. PubMed ID: 15926395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.
    Madden JR; Addo-Yobo SO; Donson AM; Liu AK; McNatt SA; Kleinschmidt-Demasters BK; Fenton LZ; Foreman NK; Smith AA
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e272-8. PubMed ID: 20736849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    Kumar R; Smith KS; Deng M; Terhune C; Robinson GW; Orr BA; Liu APY; Lin T; Billups CA; Chintagumpala M; Bowers DC; Hassall TE; Hansford JR; Khuong-Quang DA; Crawford JR; Bendel AE; Gururangan S; Schroeder K; Bouffet E; Bartels U; Fisher MJ; Cohn R; Partap S; Kellie SJ; McCowage G; Paulino AC; Rutkowski S; Fleischhack G; Dhall G; Klesse LJ; Leary S; Nazarian J; Kool M; Wesseling P; Ryzhova M; Zheludkova O; Golanov AV; McLendon RE; Packer RJ; Dunham C; Hukin J; Fouladi M; Faria CC; Pimentel J; Walter AW; Jabado N; Cho YJ; Perreault S; Croul SE; Zapotocky M; Hawkins C; Tabori U; Taylor MD; Pfister SM; Klimo P; Boop FA; Ellison DW; Merchant TE; Onar-Thomas A; Korshunov A; Jones DTW; Gajjar A; Ramaswamy V; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):807-821. PubMed ID: 33502920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced glioblastoma in a medulloblastoma patient: a case report with molecular features.
    Gessi M; Maderna E; Guzzetti S; Cefalo G; Massimino M; Solero CL; Finocchiaro G; Pollo B
    Neuropathology; 2008 Dec; 28(6):633-9. PubMed ID: 18384514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
    Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A
    Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misdiagnosing recurrent medulloblastoma: the danger of examination and imaging without histological confirmation.
    Weintraub L; Miller T; Friedman I; Abbott R; Levy AS
    J Neurosurg Pediatr; 2014 Jan; 13(1):33-7. PubMed ID: 24206345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Bone Recurrence of Medulloblastoma With MYCN Amplification and TP53 Loss: A Case Report.
    Takahashi Y; Kudo K; Ogawa K; Sato T; Kamio T; Sasaki S; Kobayashi A; Ito T; Yamamoto T; Asano K; Ohkuma H; Kurose A; Ito E; Terui K
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e593-e596. PubMed ID: 34133388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of disseminated relapsed medulloblastoma in an infant by primary radiotherapy.
    Narendran A; Monteleone PM; Steele DA; Hicks RJ; Kelleher JF
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):51-3. PubMed ID: 11196271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
    Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
    Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.